Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by ChromaDex Corporation < Previous 1 2 3 Next > ChromaDex Shares Promising Findings from First-Of-Its Kind Clinical Study to Demonstrate Oral Nicotinamide Riboside (NR) Supplementation Increases Muscle Mitochondrial Biogenesis January 17, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Appoints Leading Aging and Neurodegenerative Disease Researcher, Dr. Vilhelm Bohr, to its Scientific Advisory Board (SAB) January 12, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Named Brianna Gerber Chief Financial Officer January 05, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Shares Promising Findings from Clinical Study Demonstrating Oral Supplementation with Nicotinamide Riboside (NR) Increased Nicotinamide Adenine Dinucleotide (NAD+) Levels in the Brain and Positively Impacted Neurodegenerative Biomarkers December 27, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Reports FDA’s Conclusion that Nicotinamide Mononucleotide (NMN) May Not Be Sold or Marketed as a Dietary Supplement in the United States November 11, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Corporation Reports Third Quarter 2022 Financial Results November 02, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report Third Quarter Financial Results on Wednesday, November 2, 2022 October 26, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex and Nestlé Health Science Announce New Niagen® Commercial Supply Agreement and $5 Million Investment October 11, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex’s Tru Niagen® Won the "Most Popular Brand of the Year Award" at China International Natural Health & Nutrition Expo’s (NHNE) Prestigious Nutrition Planet Awards October 24, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC Sinopharm Xingsha to Introduce ChromaDex’s Tru Niagen® at Major Mainland China Trade Show, China International Natural Health & Nutrition Expo (NHNE) September 19, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Shares Promising Findings from Clinical Study Showcasing the Safety and Tolerability of Nicotinamide Riboside (NR) in Heart Failure With Reduced Ejection Fraction October 04, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC Thorne Research, Inc. Loses Patent Challenge Decision, Upholding ChromaDex’s Intellectual Property Held Under Exclusive License From Dartmouth College August 15, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Finalizes Commercial Joint-Venture in Asia and Announces $3.1 Million Private Placement of Common Stock October 03, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Corporation Reports Second Quarter 2022 Financial Results August 10, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022 August 02, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Announces Partnership with MyPharma2Go Corporation for Cross-Border Sales of Tru Niagen® and Tru Niagen® PRO into Brazil September 01, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex To Host Key Opinion Leader Webinar on the Transforming Benefits of Nicotinamide Riboside (NR) July 07, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Present at American Society for Nutrition (ASN), International Society of Sports Nutrition (ISSN), and Federation of American Societies for Experimental Biology (FASEB) June 15, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Present at the Oppenheimer’s 22nd Annual Consumer Growth and E-Commerce Conference June 07, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Partners with Juvenis for Cross-Border Sales of Tru Niagen® into South Korea June 02, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Signs Sinopharm Xingsha Agreement to Accelerate Cross-Border Sales of Tru Niagen® into Mainland China June 10, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Present at the LD Micro Invitational June 01, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland China May 19, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Wins International 2022 European NutraIngredients Award for Developing the Science Behind Niagen® May 17, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Corporation Reports First Quarter 2022 Financial Results May 12, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022 April 29, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Appoints Ann Cohen and Kristin Patrick to its Board of Directors April 22, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex External Research Program (CERP™) Celebrates Over 250 Research Agreements With 235+ Researchers Around the World April 14, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Launches Tru Niagen® Immune, Further Expanding Innovative Product Portfolio April 06, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Announces Issuance of Additional New U.S. Continuation Patent, Further Protecting Future Innovations March 16, 2022 From ChromaDex Corporation Via Business Wire Tickers CDXC < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
